Document Detail


Aprotinin improves pulmonary function during reperfusion in an isolated lung model.
MedLine Citation:
PMID:  11093508     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: We hypothesized that the use of aprotinin would ameliorate the reperfusion injury observed after lung transplantation because of a reduction in the inflammatory response. METHODS: We used an isolated, whole blood-perfused, ventilated rabbit lung model to study the effects of aprotinin during reperfusion. The control animals (group A, n = 8) underwent lung harvest after pulmonary arterial prostaglandin E1 injection and Euro-Collins preservation flush before saline storage for 18 hours at 4 degrees C. The experimental groups received either a low dose (3,000 KIU/mL; group B, n = 8) or a high dose (10,000 KIU/mL; group C, n = 8) of aprotinin added to the pulmonary flush before storage. Each lung was reperfused at 37 degrees C at a rate of 60 mL/min. RESULTS: The arterial partial pressure of oxygen values of group B (low-dose aprotinin) were significantly higher than those of group A (control) after 10 minutes of reperfusion (69.19 +/- 5.69 mm Hg versus 264.30 +/- 48.59 mm Hg, respectively, p = 0.001). Similar results were recorded at 20 and at 30 minutes of reperfusion. Similarly, after 10 minutes of reperfusion, the differences between groups A and C were 69.19 +/- 5.69 mm Hg versus 235.91 +/- 28.63 mm Hg, respectively (p = 0.001). CONCLUSIONS: The addition of aprotinin to the Euro-Collins pulmonary flush significantly improves arterial oxygenation in the early reperfusion period. The enhanced oxygenation suggests that aprotinin may offer protection against early reperfusion injury.
Authors:
M A Mathias; C G Tribble; J F Dietz; R P Nguyen; K S Shockey; J A Kern; I L Kron
Related Documents :
1651888 - The demonstration of dmpo superoxide adduct upon reperfusion using a low non-toxic conc...
12352318 - Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism rel...
3740568 - Microcirculatory methods for the clinical assessment of hypertension, hypotension, and ...
8614138 - Continuous warm reperfusion during heart transplantation.
23629558 - Community-based cardiovascular risk factors intervention strategies (corfis) in managin...
15083338 - Usefulness of low-priming-volume cardiopulmonary bypass circuits and dilutional ultrafi...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  70     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2000 Nov 
Date Detail:
Created Date:  2001-01-05     Completed Date:  2001-01-05     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1671-4     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aprotinin / administration & dosage,  pharmacology*
Hypertonic Solutions
Lung / physiology*
Rabbits
Reperfusion*
Reperfusion Injury / prevention & control
Serine Proteinase Inhibitors / administration & dosage,  pharmacology*
Grant Support
ID/Acronym/Agency:
R01 HL56093/HL/NHLBI NIH HHS; T32 HL07849/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Euro-Collins' solution; 0/Hypertonic Solutions; 0/Serine Proteinase Inhibitors; 9087-70-1/Aprotinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mixing collagen with fibrin glue to strengthen the sealing effect for pulmonary air leakage.
Next Document:  Lung transplantation is warranted for stable, ventilator-dependent recipients.